BDULF: AI 评分 52/100 — AI 分析 (4月 2026)

Bangkok Dusit Medical Services (BDMS) is Thailand's largest private hospital network, operating 47 hospitals across Thailand and Cambodia. The company provides a comprehensive range of medical services, wellness programs, and related healthcare businesses.

Key Facts: AI Score: 52/100 Sector: Healthcare

公司概况

概要：

Bangkok Dusit Medical Services (BDMS) is a leading healthcare provider in Thailand and Cambodia, operating a network of hospitals and offering diverse medical services, wellness programs, and pharmaceutical products, with a focus on both local and international patients and a strong dividend yield of 5.29%.

BDULF是做什么的？

Bangkok Dusit Medical Services Public Company Limited (BDMS), established in 1969 and headquartered in Bangkok, Thailand, is the largest private hospital network in Thailand. The company operates 47 hospitals in Thailand and Cambodia, managing them under six primary hospital groups: Bangkok Hospital Group, Samitivej Hospital Group, BNH Hospital, Phyathai Hospital Group, Paolo Hospital Group, and Royal Hospital Group. These groups provide a comprehensive range of medical services, from general medical care to specialized treatments, catering to both local and international patients. BDMS has expanded its services beyond traditional hospital care to include holistic clinical wellness programs, hotels, and restaurants. The company also sells health and cosmetic products and provides various support services such as accounting, health insurance, laboratory services, investment, information technology, training, skin and aesthetics telemedicine, genome sequencing, insurance brokerage, air medical transportation, facility management, property management services, and asset management services. Furthermore, BDMS is involved in manufacturing and distributing medicine and pharmaceutical products, along with e-commerce and real estate ventures, diversifying its revenue streams and solidifying its position as a comprehensive healthcare provider in the region.

BDULF的投资论点是什么？

Bangkok Dusit Medical Services presents a compelling investment case based on its dominant market position in Thailand's private healthcare sector. The company's extensive network of 47 hospitals and diverse service offerings cater to a broad patient base, driving consistent revenue. A profit margin of 14.2% and a gross margin of 36.1% demonstrate financial stability. The dividend yield of 5.29% offers an attractive return for investors. Growth catalysts include increasing medical tourism to Thailand, expansion of specialized medical services, and strategic investments in related healthcare businesses. However, potential risks include regulatory changes in the healthcare industry and economic fluctuations in Thailand and Cambodia.

BDULF在哪个行业运营？

Bangkok Dusit Medical Services operates within the growing healthcare industry in Southeast Asia, driven by increasing affluence, aging populations, and rising demand for quality medical services. Thailand is a popular destination for medical tourism, attracting patients from around the world seeking affordable and high-quality treatments. The competitive landscape includes both local and international hospital groups. BDMS differentiates itself through its extensive network, comprehensive service offerings, and strong brand reputation. The industry is expected to continue growing, driven by both domestic and international demand.

Medical - Care Facilities

Healthcare

BDULF有哪些增长机遇？

Expansion of Medical Tourism Services: Thailand is a well-known hub for medical tourism. BDMS can capitalize on this by enhancing its services for international patients, including specialized packages, multilingual support, and partnerships with international insurance providers. The global medical tourism market is projected to reach $272.7 billion by 2027, offering a substantial growth opportunity for BDMS.
Development of Specialized Medical Centers: BDMS can further develop specialized medical centers focusing on high-demand areas such as cardiology, oncology, and orthopedics. These centers can attract both local and international patients seeking advanced treatments and specialized expertise. The market for specialized medical services is growing rapidly, driven by technological advancements and increasing prevalence of chronic diseases.
Strategic Investments in Healthcare Technology: Investing in advanced healthcare technologies, such as telemedicine, AI-powered diagnostics, and robotic surgery, can improve efficiency, enhance patient outcomes, and attract tech-savvy patients. The global telemedicine market is projected to reach $41.4 billion by 2026, presenting a significant opportunity for BDMS to integrate technology into its service offerings.
Expansion into Wellness and Preventive Care: BDMS can expand its focus on wellness and preventive care services, including health screenings, personalized wellness programs, and lifestyle coaching. This can attract a broader customer base and generate recurring revenue streams. The global wellness market is estimated at over $4.7 trillion, indicating a substantial opportunity for BDMS to capitalize on the growing demand for wellness services.
Geographic Expansion within Southeast Asia: While BDMS already has a presence in Cambodia, further geographic expansion within Southeast Asia can tap into new markets and diversify revenue streams. Countries like Vietnam, Myanmar, and Laos offer significant growth potential due to their rapidly growing economies and increasing demand for quality healthcare services. Strategic partnerships and acquisitions can facilitate this expansion.

Market capitalization of $10.49 billion, reflecting its strong position in the healthcare sector.
P/E ratio of 18.95, indicating a reasonable valuation compared to earnings.
Profit margin of 14.2%, showcasing efficient operations and profitability.
Gross margin of 36.1%, demonstrating effective cost management in service delivery.
Dividend yield of 5.29%, providing a substantial income stream for investors.

BDULF提供哪些产品和服务？

Operates a network of 47 hospitals in Thailand and Cambodia.
Provides a wide range of medical services, including general and specialized treatments.
Offers holistic clinical wellness programs.
Sells health and cosmetic products.
Provides accounting, health insurance, and laboratory services.
Offers telemedicine and genome sequencing services.
Manufactures and distributes medicine and pharmaceutical products.

BDULF如何赚钱？

Generates revenue from hospital services, including inpatient and outpatient care.
Earns income from wellness programs and related health services.
Sells pharmaceutical products and medical supplies.
Provides support services such as health insurance and laboratory testing.

Local Thai patients seeking general and specialized medical care.
International patients seeking medical tourism services.
Corporations and organizations providing health benefits to their employees.
Individuals seeking wellness and preventive care services.

Extensive network of hospitals providing broad geographic coverage.
Strong brand reputation and recognition in Thailand and Southeast Asia.
Comprehensive range of medical services catering to diverse patient needs.
Established relationships with local and international insurance providers.

什么因素可能推动BDULF股价上涨？

Ongoing: Increasing medical tourism to Thailand, driven by affordable and high-quality healthcare services.
Ongoing: Expansion of specialized medical services, such as cardiology and oncology, to attract more patients.
Ongoing: Strategic investments in healthcare technology to improve efficiency and patient outcomes.

BDULF的主要风险是什么？

Potential: Economic downturns in Thailand and Cambodia, which could reduce demand for healthcare services.
Potential: Increased competition from local and international hospital groups.
Potential: Changes in government healthcare policies that could impact revenue and profitability.
Ongoing: Fluctuations in currency exchange rates, which could affect the cost of imported medical equipment and supplies.

BDULF的核心优势是什么？

Largest private hospital network in Thailand.
Comprehensive range of medical services.
Strong brand reputation.
Established medical tourism business.

BDULF的劣势是什么？

Reliance on the Thai economy.
Exposure to regulatory changes in the healthcare industry.
Competition from other hospital groups.
Potential impact from global health crises.

BDULF有哪些机遇？

Expansion into new geographic markets within Southeast Asia.
Development of specialized medical centers.
Investment in healthcare technology.
Growth in wellness and preventive care services.

BDULF面临哪些威胁？

Economic downturns in Thailand and Cambodia.
Increased competition from local and international providers.
Changes in government healthcare policies.
Fluctuations in currency exchange rates.

BDULF的竞争对手是谁？

Bloom Burton & Co. — Boutique investment bank focused on the healthcare sector. — (BIOVF)
CSPC Pharmaceutical Group Limited — Pharmaceutical company with a focus on innovative drugs. — (CSPCY)
Grifols, S.A. — Global healthcare company specializing in plasma-derived therapies. — (GIFLF)
Mothercare plc — Retailer specializing in products for mothers and young children. — (MTHRF)
Mothercare plc — Retailer specializing in products for mothers and young children. — (MTHRY)

Key Metrics

MoonshotScore: 52/100

Company Profile

CEO: Poramaporn Prasarttong-Osoth
Headquarters: Bangkok, TH
Founded: 2009

AI Insight

AI analysis pending for BDULF

OTC Tier: OTC Other
Disclosure Status: Unknown

常见问题

What does Bangkok Dusit Medical Services Public Company Limited do?

Bangkok Dusit Medical Services (BDMS) is the largest private hospital network in Thailand, operating 47 hospitals across Thailand and Cambodia. It provides a comprehensive range of medical services, from general care to specialized treatments like cardiology and oncology, catering to both local and international patients. Beyond hospital services, BDMS also offers wellness programs, sells health and cosmetic products, and provides support services such as health insurance and laboratory testing, making it a comprehensive healthcare provider in the region.

What do analysts say about BDULF stock?

AI analysis is currently pending for BDULF. Generally, healthcare stocks are evaluated based on factors such as revenue growth, profit margins, and market share. Investors also consider the company's ability to innovate and adapt to changing healthcare trends. BDULF's dividend yield of 5.29% may be an important factor for investors seeking income. Further analysis is needed to provide a comprehensive assessment of the stock's potential.

What are the main risks for BDULF?

The main risks for Bangkok Dusit Medical Services include economic downturns in Thailand and Cambodia, which could reduce demand for healthcare services. Increased competition from local and international hospital groups could also put pressure on revenue and profitability. Changes in government healthcare policies and fluctuations in currency exchange rates are additional factors that could impact the company's performance. As an OTC stock, BDULF carries additional risks related to low liquidity and limited financial disclosure.